These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 25066864)

  • 1. Lysosome size, motility and stress response regulated by fronto-temporal dementia modifier TMEM106B.
    Stagi M; Klein ZA; Gould TJ; Bewersdorf J; Strittmatter SM
    Mol Cell Neurosci; 2014 Jul; 61():226-40. PubMed ID: 25066864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways.
    Chen-Plotkin AS; Unger TL; Gallagher MD; Bill E; Kwong LK; Volpicelli-Daley L; Busch JI; Akle S; Grossman M; Van Deerlin V; Trojanowski JQ; Lee VM
    J Neurosci; 2012 Aug; 32(33):11213-27. PubMed ID: 22895706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated TMEM106B levels exaggerate lipofuscin accumulation and lysosomal dysfunction in aged mice with progranulin deficiency.
    Zhou X; Sun L; Brady OA; Murphy KA; Hu F
    Acta Neuropathol Commun; 2017 Jan; 5(1):9. PubMed ID: 28126008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of the frontotemporal dementia risk factor TMEM106B causes C9orf72-dependent alterations in lysosomes.
    Busch JI; Unger TL; Jain N; Tyler Skrinak R; Charan RA; Chen-Plotkin AS
    Hum Mol Genet; 2016 Jul; 25(13):2681-2697. PubMed ID: 27126638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The FTLD risk factor TMEM106B and MAP6 control dendritic trafficking of lysosomes.
    Schwenk BM; Lang CM; Hogl S; Tahirovic S; Orozco D; Rentzsch K; Lichtenthaler SF; Hoogenraad CC; Capell A; Haass C; Edbauer D
    EMBO J; 2014 Mar; 33(5):450-67. PubMed ID: 24357581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration.
    Rusmini P; Cortese K; Crippa V; Cristofani R; Cicardi ME; Ferrari V; Vezzoli G; Tedesco B; Meroni M; Messi E; Piccolella M; Galbiati M; Garrè M; Morelli E; Vaccari T; Poletti A
    Autophagy; 2019 Apr; 15(4):631-651. PubMed ID: 30335591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The frontotemporal lobar degeneration risk factor, TMEM106B, regulates lysosomal morphology and function.
    Brady OA; Zheng Y; Murphy K; Huang M; Hu F
    Hum Mol Genet; 2013 Feb; 22(4):685-95. PubMed ID: 23136129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia.
    Nicholson AM; Finch NA; Wojtas A; Baker MC; Perkerson RB; Castanedes-Casey M; Rousseau L; Benussi L; Binetti G; Ghidoni R; Hsiung GY; Mackenzie IR; Finger E; Boeve BF; Ertekin-Taner N; Graff-Radford NR; Dickson DW; Rademakers R
    J Neurochem; 2013 Sep; 126(6):781-91. PubMed ID: 23742080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TMEM106B drives lung cancer metastasis by inducing TFEB-dependent lysosome synthesis and secretion of cathepsins.
    Kundu ST; Grzeskowiak CL; Fradette JJ; Gibson LA; Rodriguez LB; Creighton CJ; Scott KL; Gibbons DL
    Nat Commun; 2018 Jul; 9(1):2731. PubMed ID: 30013069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of TMEM106B and PGRN leads to severe lysosomal abnormalities and neurodegeneration in mice.
    Feng T; Mai S; Roscoe JM; Sheng RR; Ullah M; Zhang J; Katz II; Yu H; Xiong W; Hu F
    EMBO Rep; 2020 Oct; 21(10):e50219. PubMed ID: 32852886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased lysosomal biogenesis in activated microglia and exacerbated neuronal damage after traumatic brain injury in progranulin-deficient mice.
    Tanaka Y; Matsuwaki T; Yamanouchi K; Nishihara M
    Neuroscience; 2013 Oct; 250():8-19. PubMed ID: 23830905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Lysosomal Trafficking Transmembrane Protein 106B Is Linked to Cell Death.
    Suzuki H; Matsuoka M
    J Biol Chem; 2016 Oct; 291(41):21448-21460. PubMed ID: 27563066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane orientation and subcellular localization of transmembrane protein 106B (TMEM106B), a major risk factor for frontotemporal lobar degeneration.
    Lang CM; Fellerer K; Schwenk BM; Kuhn PH; Kremmer E; Edbauer D; Capell A; Haass C
    J Biol Chem; 2012 Jun; 287(23):19355-65. PubMed ID: 22511793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of TMEM106B potentiates lysosomal and FTLD-like pathology in progranulin-deficient mice.
    Werner G; Damme M; Schludi M; Gnörich J; Wind K; Fellerer K; Wefers B; Wurst W; Edbauer D; Brendel M; Haass C; Capell A
    EMBO Rep; 2020 Oct; 21(10):e50241. PubMed ID: 32929860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The FTLD Risk Factor TMEM106B Regulates the Transport of Lysosomes at the Axon Initial Segment of Motoneurons.
    Lüningschrör P; Werner G; Stroobants S; Kakuta S; Dombert B; Sinske D; Wanner R; Lüllmann-Rauch R; Wefers B; Wurst W; D'Hooge R; Uchiyama Y; Sendtner M; Haass C; Saftig P; Knöll B; Capell A; Damme M
    Cell Rep; 2020 Mar; 30(10):3506-3519.e6. PubMed ID: 32160553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TiME for TMEM106B.
    Debaisieux S; Schiavo G
    EMBO J; 2014 Mar; 33(5):405-6. PubMed ID: 24497553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of TMEM106B, the frontotemporal lobar degeneration-associated protein, in normal and diseased human brain.
    Busch JI; Martinez-Lage M; Ashbridge E; Grossman M; Van Deerlin VM; Hu F; Lee VM; Trojanowski JQ; Chen-Plotkin AS
    Acta Neuropathol Commun; 2013 Jul; 1():36. PubMed ID: 24252750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TFEB regulates lysosomal positioning by modulating TMEM55B expression and JIP4 recruitment to lysosomes.
    Willett R; Martina JA; Zewe JP; Wills R; Hammond GRV; Puertollano R
    Nat Commun; 2017 Nov; 8(1):1580. PubMed ID: 29146937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of TMEM106B amyloid fibrils provides an updated view of TMEM106B biology in health and disease.
    Perneel J; Rademakers R
    Acta Neuropathol; 2022 Nov; 144(5):807-819. PubMed ID: 36056242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III.
    Jun MH; Han JH; Lee YK; Jang DJ; Kaang BK; Lee JA
    Mol Brain; 2015 Dec; 8():85. PubMed ID: 26651479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.